Source: International Congress 2019 – Current perspectives in sleep-disordered breathing
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
J. Pépin (Grenoble, France), R. Schwab (Philadelphia, United States of America), C. Shapiro (Toronto, Canada), J. Hedner (Gothenburg, Sweden), M. Ahmed (Cleveland, United States of America), N. Foldvary-Schaefer (Cleveland, United States of America), P. Strollo (Pittsburgh, United States of America), G. Mayer (Schwalmstadt/Marburg, Germany), K. Sarmiento (San Francisco, United States of America), M. Baladi (Palo Alto, United States of America), P. Chandler (Palo Alto, United States of America), L. Lee (Palo Alto, United States of America), A. Malhotra (La Jolla, United States of America). Long-term efficacy of solriamfetol for excessive sleepiness in narcolepsy or obstructive sleep apnea. 1998

Member's Comments

No comment yet.

Related content which might interest you: Pitolisant efficacy in excessive daytime sleepiness for patients with obstructive sleep apnea Source: Virtual Congress 2021 – Advances in therapeutic plans for sleep disordered breathing Year: 2021 Pitolisant efficacy in excessive daytime sleepiness for patients with obstructive sleep apnea Source: Sleep and Breathing Conference 2021 Year: 2021 Diagnosing excessive daytime sleepiness in obstructive sleep apnoea Source: 5th Sleep and Breathing Conference Year: 2019 Determinants of subjective sleepiness in suspected obstructive sleep apnoea Source: Annual Congress 2008 - Assessment of sleep apnoea Year: 2008 Daytime sleepiness in patients with treated obstructive sleep apnea Source: Eur Respir J 2007; 30: Suppl. 51, 594s Year: 2007 Efficacy and safety of modafinil as an adjunctive therapy for excessive sleepiness associated with obstructive sleep apnoea Source: Eur Respir J 2004; 24: Suppl. 48, 116s Year: 2004 The use of beta-blockers is not associated with increased daytime sleepiness in patients with obstructive sleep apnoea Source: International Congress 2019 – Beyond continuous positive airway pressure treatment Year: 2019 Efficacy of adaptive servo-ventilation on residual sleepiness in patients with obstructive sleep apnea syndrome Source: Annual Congress 2008 - Outcome of adaptive servo ventilation in sleep apnoea Year: 2008 What is the impact of obstructive sleep apnea hypopnea syndrome and daytime sleepiness on work performance? Source: International Congress 2017 – Variation in th phenotypes and symptoms of obstructive sleep apnoea Year: 2017 Daytime sleepiness and quality of life in patients with obstructive sleep apnea Source: Virtual Congress 2021 – Pathophysiology and clinical consequences of obstructive sleep apnoea Year: 2021 Predictors of residual sleepiness in adequately treated obstructive sleep apnoea patients Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea Year: 2009 Short- and long-term prevalence of complex sleep apnoea in patients treated for obstructive sleep apnoea Source: Annual Congress 2009 - Complex sleep apnoea and adaptive servo ventilation Year: 2009 Residual sleepiness in obstructive sleep apnoea: phenotype and related symptoms Source: Eur Respir J 2011; 37: 98-105 Year: 2011 The associations between sleep bruxism and obstructive sleep apnea Source: 5th Sleep and Breathing Conference Year: 2019 Predictors of long-term PAP-adherence in obstructive sleep apnea syndrome Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health Year: 2012 Ato-oxy as the first successful pharmacotherapy for obstructive sleep apnoea Source: International Congress 2019 – New horizons for pharmacotherapy of sleep-disordered breathing: from bench to bedside Year: 2019 Prolonged symptoms and sleep quality after hospitalization for covid-19 in patients with obstructive sleep apnoea Source: Virtual Congress 2021 – Different treatment modalities and impact of comorbidities on sleep disordered breathing Year: 2021 Return of sleep apnoea and sleep fragmentation following CPAP withdrawal in patients with obstructive sleep apnoea Source: Eur Respir J, 53 (5) 1802351; 10.1183/13993003.02351-2018 Year: 2019